172 related articles for article (PubMed ID: 33999292)
1. Identification of a novel mutation in MEF2C gene in an atypical patient with frontotemporal lobar degeneration.
Adrião A; Santana I; Ribeiro C; Cancela ML; Conceição N; Grazina M
Neurol Sci; 2022 Jan; 43(1):319-326. PubMed ID: 33999292
[TBL] [Abstract][Full Text] [Related]
2. Genetic contribution of FUS to frontotemporal lobar degeneration.
Van Langenhove T; van der Zee J; Sleegers K; Engelborghs S; Vandenberghe R; Gijselinck I; Van den Broeck M; Mattheijssens M; Peeters K; De Deyn PP; Cruts M; Van Broeckhoven C
Neurology; 2010 Feb; 74(5):366-71. PubMed ID: 20124201
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
[TBL] [Abstract][Full Text] [Related]
4. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
5. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Rubino E; Rainero I; Chiò A; Rogaeva E; Galimberti D; Fenoglio P; Grinberg Y; Isaia G; Calvo A; Gentile S; Bruni AC; St George-Hyslop PH; Scarpini E; Gallone S; Pinessi L;
Neurology; 2012 Oct; 79(15):1556-62. PubMed ID: 22972638
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
[TBL] [Abstract][Full Text] [Related]
7. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
[TBL] [Abstract][Full Text] [Related]
8.
Adrião A; Mariano S; Mariano J; Gavaia PJ; Cancela ML; Vitorino M; Conceição N
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238675
[TBL] [Abstract][Full Text] [Related]
9. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Gijselinck I; Engelborghs S; Maes G; Cuijt I; Peeters K; Mattheijssens M; Joris G; Cras P; Martin JJ; De Deyn PP; Kumar-Singh S; Van Broeckhoven C; Cruts M
Arch Neurol; 2010 May; 67(5):606-16. PubMed ID: 20457961
[TBL] [Abstract][Full Text] [Related]
10. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
[TBL] [Abstract][Full Text] [Related]
11. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
[TBL] [Abstract][Full Text] [Related]
12. Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients.
Lattante S; Le Ber I; Camuzat A; Pariente J; Brice A; Kabashi E;
Neurobiol Aging; 2013 Aug; 34(8):2078.e5-6. PubMed ID: 23582661
[TBL] [Abstract][Full Text] [Related]
13. TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course.
Borroni B; Archetti S; Del Bo R; Papetti A; Buratti E; Bonvicini C; Agosti C; Cosseddu M; Turla M; Di Lorenzo D; Pietro Comi G; Gennarelli M; Padovani A
Rejuvenation Res; 2010 Oct; 13(5):509-17. PubMed ID: 20645878
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
15. A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration.
Nakamura M; Bieniek KF; Lin WL; Graff-Radford NR; Murray ME; Castanedes-Casey M; Desaro P; Baker MC; Rutherford NJ; Robertson J; Rademakers R; Dickson DW; Boylan KB
Acta Neuropathol; 2015 Jul; 130(1):145-57. PubMed ID: 25917047
[TBL] [Abstract][Full Text] [Related]
16. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
17. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
18. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France.
Lattante S; Le Ber I; Camuzat A; Brice A; Kabashi E
Neurobiol Aging; 2013 Jun; 34(6):1709.e1-2. PubMed ID: 23182804
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
